Your Location:
Home >
Browse articles >
A Randomized,Double-blind,Multi-center Clinical Trial of Tengfu Jiangya Tablets Combined with Valsartan/Amlodipine in Treatment of Grade 2 Hypertension with Hyperactivity of Liver Yang
A Randomized,Double-blind,Multi-center Clinical Trial of Tengfu Jiangya Tablets Combined with Valsartan/Amlodipine in Treatment of Grade 2 Hypertension with Hyperactivity of Liver Yang
Enhanced Publication- “The latest research has found that the combination of Tengshu Jiangya tablets and valsartan/amlodipine can effectively reduce blood pressure, improve the compliance rate, improve traditional Chinese medicine syndrome, and ensure clinical safety in the treatment of liver yang hyperactivity syndrome in grade 2 hypertension.”
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 30, Issue 9, Pages: 83-92(2024)
DOI: 10.13422/j.cnki.syfjx.20241196
Scan QR Code
AI Introduction
Full Text(HTML)
Figs( 0 ) Tabs( 12 )
References
Publication Info
Metrics
358
Views
196
Downloads
0
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Mechanism of Xixintang in Protecting Blood-brain Barrier in Alzheimer's Disease Model Rats Based on AQP4 Polarization
Transcriptome-based Mining of Genes Involved in Regulation of Cyclopeptide B Synthesis in Pseudostellaria heterophylla
Traditional Chinese Medicine Treatment of Colorectal Cancer Based on AMPK Signaling Pathway: A Review
Pharmacological Effect and Mechanism of Volatile Oil Microemulsion of Atractylodes chinensis in Relieving Depression
Construction of Saikosaponin D Multifunctional Liposomes and Evaluation of Its Anti-liver Cancer Efficacy and Targeting
Related Author
QI Yuchen
LI Yunlun
WU Yujie
WANG Haiquan
WANG Yu
Related Institution
Shandong University of Traditional Chinese Medicine
Affiliated Hospital of Shandong University of Traditional Chinese Medicine


